. 2017 Jun 16;96(24):e6817. doi: 10.1097/MD.0000000000006817
Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the Creative Commons Attribution-No Derivatives License 4.0, which allows for redistribution, commercial, and noncommercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
Table 3.
PSA response information: patients treated with enzalutamide.
